Literature DB >> 32347068

[Application of immune cell infiltration in the diagnosis and prognosis of non-small cell lung cancer].

Huihui Wan1, Zhenhao Liu2,3, Xiaoxiu Tan1, Guangzhi Wang4, Yong Xu1, Lu Xie2, Yong Lin1.   

Abstract

Immune cell infiltration is of great significance for the diagnosis and prognosis of cancer. In this study, we collected gene expression data of non-small cell lung cancer (NSCLC) and normal tissues included in TCGA database, obtained the proportion of 22 immune cells by CIBERSORT tool, and then evaluated the infiltration of immune cells. Subsequently, based on the proportion of 22 immune cells, a classification model of NSCLC tissues and normal tissues was constructed using machine learning methods. The AUC, sensitivity and specificity of classification model built by random forest algorithm reached 0.987, 0.98 and 0.84, respectively. In addition, the AUC, sensitivity and specificity of classification model of lung adenocarcinoma and lung squamous carcinoma tissues constructed by random forest method 0.827, 0.75 and 0.77, respectively. Finally, we constructed a prognosis model of NSCLC by combining the immunocyte score composed of 8 strongly correlated features of 22 immunocyte features screened by LASSO regression with clinical features. After evaluation and verification, C-index reached 0.71 and the calibration curves of three years and five years were well fitted in the prognosis model, which could accurately predict the degree of prognostic risk. This study aims to provide a new strategy for the diagnosis and prognosis of NSCLC based on the classification model and prognosis model established by immune cell infiltration.

Entities:  

Keywords:  LASSO regression; NSCLC; classification model; immune cell infiltration; machine learning; prognosis model; random forest

Year:  2020        PMID: 32347068     DOI: 10.13345/j.cjb.190232

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  1 in total

1.  CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer.

Authors:  Bei Ji; Lili Qiao; Wei Zhai
Journal:  Dig Dis Sci       Date:  2022-05-27       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.